Sertraline Tablets

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DLA TROOP SUPPORT

Contract Value

Not provided

Codes & Classification
Solicitation Number

SPE2D2-26-D-0012

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

Hauppauge, New York, UNITED STATES

SourceSAM
Documents1
The Defense Logistics Agency (DLA) Troop Support, a federal office under the Department of Defense, has issued an award notice for the procurement of Sertraline Tablets, as indicated by procurement identifier SPE2D2-26-D-0012. This contract represents a follow-on award, signifying the continuation of previous efforts to supply this essential pharmaceutical product. The primary objective of this procurement is to ensure a reliable and consistent supply of Sertraline Tablets, a medication widely used in the treatment of depression and other mental health conditions. The scope of the contract encompasses the manufacturing and delivery of pharmaceutical-grade Sertraline Tablets, adhering to stringent quality and regulatory standards as outlined under NAICS Code 325412 (Pharmaceutical Preparation Manufacturing). The associated Product Service Code is 6505, which covers drugs and biologicals. The place of performance for this contract is Hauppauge, New York, USA. Contractors engaged in this opportunity are expected to have the capability to manufacture and deliver pharmaceutical preparations in compliance with federal requirements, ensuring timely and secure distribution to meet the needs of the Department of Defense. Key deliverables under this contract include the production and supply of Sertraline Tablets in accordance with the specifications and quantities determined by DLA Troop Support. Contractors must demonstrate robust quality assurance processes and the ability to maintain consistent product availability throughout the contract lifecycle. The procurement is managed by DLA Troop Support, with Christopher Newman serving as the primary point of contact ([email protected], 445-737-7371) and Jason Wray as the secondary contact ([email protected], 445-737-6304). Interested parties can access further details and the official award notice via the SAM.gov opportunity ID 3691a507274c464e84228c5a062642e8. This award notice is currently active, and all relevant documentation is available through the provided SAM.gov link. Contractors specializing in pharmaceutical preparation manufacturing, particularly those with experience in supplying to federal agencies, are well-positioned to align with the requirements and objectives of this contract. No specific set-aside requirements or special considerations are indicated in the available information. Overall, this procurement activity underscores the Department of Defense’s commitment to ensuring the availability of critical medications for its personnel, with an emphasis on quality, reliability, and compliance with federal standards.